Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Kyndryl
KD
$2.84B
| $2.36M | ﹤0.01% |
+88,766
| New | +$2.41M |
|
|
NB
1727
NioCorp Developments
NB
$651M
| $2.35M | ﹤0.01% |
443,898
-65,495
| -13% | -$451K |
|
1728
Allstate
ALL
$65.1B
| $2.34M | ﹤0.01% |
11,221
+3,514
| +46% | +$719K |
|
1729
CALL
State Street Consumer Staples Select Sector SPDR ETF
XLP
$15.1B
| $2.33M | ﹤0.01% |
30,000
| – | – |
|
1730
PUT
Deere & Co
DE
$170B
| $2.33M | ﹤0.01% |
5,000
+1,200
| +32% | +$563K |
|
1731
Federal Agricultural Mortgage
AGM
$2.38B
| $2.31M | ﹤0.01% |
+13,130
| New | +$2.21M |
|
1732
CALL
Capital One
COF
$133B
| $2.3M | ﹤0.01% |
9,500
+7,600
| +400% | +$1.69M |
|
1733
Conagra Brands
CAG
$7.81B
| $2.3M | ﹤0.01% |
+132,932
| New | +$2.36M |
|
|
VOYG
1734
CALL
Voyager Technologies
VOYG
$2.11B
| $2.29M | ﹤0.01% |
+87,700
| New | +$2.38M |
|
|
BMNR
1735
BitMine Immersion Technologies
BMNR
$15B
| $2.29M | ﹤0.01% |
+84,407
| New | +$3.42M |
|
1736
PUT
Apollo Global Management
APO
$78.6B
| $2.29M | ﹤0.01% |
15,800
-6,400
| -29% | -$850K |
|
|
OKLO
1737
PUT
Oklo
OKLO
$8.24B
| $2.28M | ﹤0.01% |
31,800
-50,000
| -61% | -$5.58M |
|
|
JHG
1738
CALL
DELISTED
Janus Henderson
JHG
| $2.28M | ﹤0.01% |
+47,900
| New | +$2.12M |
|
1739
CALL
State Street Communication Services Select Sector SPDR ETF
XLC
$22.8B
| $2.27M | ﹤0.01% |
19,300
+5,800
| +43% | +$668K |
|
1740
Fortinet
FTNT
$113B
| $2.27M | ﹤0.01% |
28,571
+11,102
| +64% | +$921K |
|
1741
National Vision
EYE
$1.48B
| $2.27M | ﹤0.01% |
87,867
-129,213
| -60% | -$3.48M |
|
1742
Stevanato
STVN
$6.2B
| $2.26M | ﹤0.01% |
112,253
+98,013
| +688% | +$2.28M |
|
1743
CALL
Moderna
MRNA
$63.4B
| $2.25M | ﹤0.01% |
76,400
+59,700
| +357% | +$1.62M |
|
|
CALY
1744
Callaway Golf Company
CALY
$2.76B
| $2.25M | ﹤0.01% |
192,839
-2,303,436
| -92% | -$24.3M |
|
1745
Nurix Therapeutics
NRIX
$2.8B
| $2.25M | ﹤0.01% |
118,481
-3,102
| -3% | -$44.6K |
|
1746
CALL
UiPath
PATH
$8.63B
| $2.24M | ﹤0.01% |
136,600
-148,400
| -52% | -$2.31M |
|
1747
HCA Healthcare
HCA
$92.8B
| $2.24M | ﹤0.01% |
4,788
-2,382
| -33% | -$1.11M |
|
1748
Altria Group
MO
$114B
| $2.23M | ﹤0.01% |
38,636
-1,694,039
| -98% | -$102M |
|
1749
ASML
ASML
$670B
| $2.22M | ﹤0.01% |
2,076
-135,252
| -98% | -$141M |
|
1750
Takeda Pharmaceutical
TAK
$58.6B
| $2.2M | ﹤0.01% |
+141,024
| New | +$2.02M |
|
Similar funds
Dmitry Balyasny's Q4 2025 Portfolio in Review
As of Q4 2025, Dmitry Balyasny held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Dmitry Balyasny withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Dmitry Balyasny opened a new position in Avidity Biosciences worth $436M.
- Dmitry Balyasny's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Dmitry Balyasny added most to Amazon in Q4 2025, an estimated $807M increase.
- Dmitry Balyasny's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Dmitry Balyasny fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Dmitry Balyasny's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Dmitry Balyasny opened 809 new positions and closed 643 in Q4 2025.
- Dmitry Balyasny's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.